Insider trade

Mirum Pharmaceuticals (MIRM)Director sold ~$114K

Saira Ramasastry, Director at Mirum Pharmaceuticals, sold ~$114K of Mirum Pharmaceuticals shares.

~$114K
Approx. value · 2,500 sh @ $45.74
Traded
Jun 3, 2025
Filed
Jun 4, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 2, 2025InsiderDirector sold ~$263K of MIRM shares in the open market
  2. Jun 3, 2025 · this disclosureInsiderDirector sold ~$114K of MIRM shares in the open market

What came next

  1. Jun 11, 2025InsiderDirector sold ~$155K of MIRM shares in the open market
  2. Jul 2, 2025InsiderOfficer sold ~$27K of MIRM shares in the open market
  3. Jul 3, 2025InsiderOfficer sold ~$23K of MIRM shares in the open market
  4. Aug 7, 2025Insider · 2 peopleInsiders: 2 sales (~$2.8M)
  5. Aug 11, 2025InsiderCEO sold ~$2.48M of MIRM shares in the open market
  6. Sep 11, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
  7. Sep 12, 2025InsiderCFO sold ~$728K of MIRM shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Mirum Pharmaceuticals

For Mirum Pharmaceuticals, OQRO holds 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MIRM page.

Other recent filings by Saira Ramasastry, Director

The full history of Saira Ramasastry, Director is on the profile page.

How this filing works

Other disclosures at Mirum Pharmaceuticals

Everything OQRO holds on this company is on its MIRM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data